2.A case of secondary bleeding after tonsentectomy.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(19):1530-1531
One case of secondary bleeding repeatedly after tonsillectomy. Secondary bleeding after tonsillectomy seldom happen to us. When the event occurs medical staff has to take effect way to control the bleeding immediately. Accumulated quantity of bleeding must be controlled to the lowest point as soon as possible. Other wise the bleeding may lead to death. This point should be considered by medical staff.
Humans
;
Postoperative Hemorrhage
;
etiology
;
Tonsillectomy
;
adverse effects
3.Clinical application of DSA in cerebrovascular disease
Sherong GAO ; Zhiwei AN ; Honggang SUN
Clinical Medicine of China 2010;26(8):792-794
Objective To investigate the consequence of digital subtraction angiography (DSA) in different diseases types and inquire into the prevention of its complications. Methods the DSA results of 65 cases with cerebrovascular disease were analyzed and the relationship were observed between symptom and cerebrovascular pathology, the complications intra and after operation as well. Results Among the 65 DSA examinations, intracranial or extracraniai vascular abnormality were found in 58 cases, the positive detection rate was 89. 23% . Several subsequent coplications such as 1 case puncture site hematoma,l case angiospasm,l case epileptic attack and 1 case cerebellum infarction were observed . Conclusions DSA examination can assist in diagnosing cerebrovascular disease,it is a traumatic but reliable examination method.
4.Clinical Study of the Multi-organ Lesions and the Occurrence of Coronary Aneurysms of 92 Pediatric Inpatients with KD.
Daiming ZHENG ; Xiaohui MENG ; Zhiwei GAO
Journal of Medical Research 2006;0(01):-
Objective To investigate the multi-organ lesions and the occurrence of coronary aneurysms in children with Kawasaki disease(KD).Methods 92 pediatric inpatients with KD were enrolled and studied.The organs involved and coronary aneurysms(CAA)were determined by checking blood routine,urine routine,stool routine,chest X-ray,electrokardiogram,liver function,echocardiogram,and clinical manifestation.Results The incidence of various organs involved in 92 patients with KD:heart 71.7%;lung 37.0%;liver 34.8%;brain 12.0%;kidney 18.5%;gastrointestinal tract 15.2%;spleen 2.2%;gallbladder 1.1%;joints 9.8%.In addition,the rate of two organs involved simultaneously was 40.2%,three and more 34.8%.The incidence of CAA in brain lesion,joints lesion and pericardial effusion complications of KD was 45.5%,44.4%,and 41.7%,respectively.Conclusions The data shows that the incidence of heart involvement in the sick-children with KD is highest,and other organs,such as lung,liver,kidney,gastrointestinal tract,brain and joints are involved in turn.The incidence of 2 and more organs involved simultaneously amounts to75.0%.CAA is the most serious complication of KD.Our study suggests that the incidence of CAA is obviously high in these lesions of brain,joints and pericardial effusion involvement in KD.
5.Advances in molecular targeted therapy for soft tissue sarcomas
Tian GAO ; Zhengfu FAN ; Zhiwei FANG
Chinese Journal of Clinical Oncology 2017;44(1):7-13
Sarcomas are tumors of mesenchymal origin that account for approximately 1%of human cancers. There are at least 60 dif-ferent subtypes of soft tissue sarcoma (STS). However, most tumor types are highly malignant tumors that lack an optimal therapeutic agent. Although gastrointestinal stromal tumor (GIST) responds well to imatinib, other types of STSs remain challenging because of their heterogeneous genetic and clinical features and poor prognosis. In recent years, the field of molecular targeted therapy has pro-gressed rapidly. Patients with advanced disease can receive individualized treatment to improve their quality of life. This review focus-es on the targeted therapies that have been evaluated for advanced non-GIST STS. Other promising novel therapeutic agents that are currently in the early phases of investigation are also presented.
6.Laparoscopic Filling with Pedicled Greater Retina for Hepatic Cysts Bigger Than 10 cm in Diameter:a Report of 36 Cases
Jiping LIU ; Guosheng ZHANG ; Zhiwei GAO
Chinese Journal of Minimally Invasive Surgery 2015;(7):632-634
Objective To evaluate the effects of laparoscopic filling with pedicled greater retina for hepatic cysts. Methods Clinical data were reviewed on 36 patients with hepatic cysts undergoing laparoscopic filling with pedicled greater retina from January 2010 to May 2014.The diameters of cysts ranged from 10 to 26 cm, with a diameter smaller than 20 cm in 29 patients and bigger than 20 cm in 7 patients.Laparoscopic fenestration of hepatic cysts was performed to destroy cyst cells with iodine and absolute alcohol. Pedicled greater retina was used for filling the cavity of cysts. Results The procedures were completed smoothly.The operative time was 45-115 min, with an average of (80.4 ±13.1) min.No abdominal cavity infection happened.Primary healing of abdominal incision was achieved in all the patients.The postoperative hospital stay was 5-10 d, with an average of (6.4 ±1.2) d.All the 36 patients were followed up for 6-12 months with a mean of (9.3 ±1.5) months.None of the patients showed recurrence under liver B-ultrasonography or CT scanning. Conclusion Laparoscopic filling with pedicled greater retina for hepatic cysts has advantages of minimal invasion, quick postoperative recovery, short hospital stay, and good results.
7.Study on the Bioavailability of 2 Kinds of Cyclosporin A in Human Body
Zhiwei GAO ; Zhongdong LI ; Xiaojin SHI ; Zheng JIAO ; Mingkang ZHONG
China Pharmacy 2005;0(22):-
0.05)except that the tmax of the testing preparation was faster than that of the control drug.The relative bioavailability of the testing drug was(93.83?15.21)%.CONCLUSION:The AUC0~24,AUC0~∞and Cmax of 2 preparations are similar,but there is a significant difference in tmax.
8.The effects of different therapies and formulas on CRH mRNA expression in Hypothalamus of rats with chronic psychological stress
Can YAN ; Lili WU ; Zhiwei XU ; Li GAO
Chinese Pharmacological Bulletin 2003;0(10):-
Aim The purpose of this study was to investigate mec ha nism of different therapies and formulas regulating chronic psychological stress . Methods The way of chronic bandaging and confining activity space w as adopted to establish chronic psychological stress rat model. The effects of d ifferent therapies and formulas on CRH mRNA expression in Hypothalamus were anal yzed by RT-PCR method. Results There was significant increase of CRH mRNA expression in Hypothalamus of rats with continual 2 wk psychological stres s(P
9.Study on Brainwave Music Software of Brainwave Therapeutic Apparatus
Zhiwei NIU ; Lifan MENG ; Xiaojian GAO ; Chunqiu DONG
Chinese Medical Equipment Journal 2003;0(10):-
Objective To put forward a design of the software of brainwave therapeutic apparatus based on the MCU. Methods Based on principle of electroencephalogram music treatment, several sound synthesis techniques were analyzed and contrasted. A simple and easily-realized one was selected and analyzed in detail. Finally, the output of brainwave therapeutic apparatus was tested and errors were analyzed. Results The selected scheme can effectively generate brainwave music. Conclusion According to the scheme, a low-cost and reliable brainwave therapeutic apparatus can be made by using the MCU.
10.Predicting pharmacokinetics of anti-cancer drug, famitinib in human using physiologically based pharmacokinetic model.
Mingming YU ; Zhiwei GAO ; Xiaoyan CHEN ; Dafang ZHONG
Acta Pharmaceutica Sinica 2014;49(12):1684-8
This study is to establish physiologically based pharmacokinetic (PBPK) models of famitinib in rat and monkey, and then to predict the pharmacokinetics and tissue distribution of famitinib in human based on the PBPK models. According to published paper, previous studies and the chemical properties of famitinib predicted by ACD/ADME suite and SimCYP, the PBPK models of rat and monkey were established and optimized using GastroPlus. And then, the PBPK models were applied to predict the pharmacokinetic and tissue distribution of famitinib in human. The results showed that the PBPK models of rat and monkey can fit the observed data well, and the AUC0-∞, ratios of observed and calculated data in rat and monkey were 1.00 and 0.97, respectively. The AUC0-∞, ratios of observed and predicted data in human were 1.63 (rat to human) and 1.57 (monkey to human), respectively. The rat and monkey PBPK models of famitinib were well established, and the PBPK models were applied in predicting pharmacokinetic of famitinib in human successfully. Hence, the PBPK model of famitinib in human could be applied in future drug-drug interaction study.